Supreme Court agrees to hear appeal about popular MS drug

The U.S. Supreme Court will hear an appeal from the maker of Copaxone, used to treat MS, in response to its patent protection being withdrawn early

The U.S. Supreme Court may be able to help Teva Pharmaceutical Industries over a patent dispute on a key drug used to treat multiple sclerosis (MS). 

Teva is trying to keep other companies from providing cheaper generics as an option to Copaxone (Glatiramer acetate). The new alternatives could be offered to patients as soon as May, when Copaxone is scheduled to lose its patent protection.

Contributing Author

author image

Ed Silverstein

Ed Silverstein is a veteran writer and editor for magazines, websites and newspapers. A graduate of Harvard's Kennedy School of Government, he has won several...

Bio and more articles

Join the Conversation

Advertisement. Closing in 15 seconds.